More Highlights From the XIV International AIDS Conference
Last week's International AIDS Conference in Barcelona brought plenty of intriguing news on HIV treatment, and The Body was there to cover it all. Read coverage from our outstanding physician reporters, and tune in to audio and video feeds straight from the conference!
Tenofovir Works as First-Line, Hepatitis B Treatment
Tenofovir was one of the stars of this year's conference, with researchers hailing its effectiveness in a wide variety of treatment situations. One widely discussed study compared a drug regimen with tenofovir to one with d4T, and found that tenofovir worked just as well, but with fewer side effects. More from Cal Cohen, M.D.
Another small study found that, in people coinfected with HIV and HBV, tenofovir dramatically sliced the hepatitis B viral load. Andrew Pavia, M.D. has more on this exciting finding.
T-20 Shows Promising Results
Results from two key T-20 studies involving treatment-experienced patients are in, and they look extremely encouraging. Pablo Tebas, M.D. reports.
Bad News on Immune-System Recovery
Even if you're in a relationship where both of you are HIV positive, here's why safe sex is extremely important: A Boston-area man whose immune system had learned to fight off his HIV infection watched his health decline rapidly after he was superinfected with a different strain of HIV during unprotected sex. Keith Henry, M.D. provides the details.
Good News for Mixed-Status Couples
There's new hope for HIV-negative women who want to have a child with an HIV-positive man! One study of more than 4,000 inseminations (in more than 1,500 couples) found not one single transmission of HIV. Dr. Judy Aberg reports on this presentation.
Structured Treatment Interruptions
Research continues on the different ways that treatment interruptions may improve care. Read Cal Cohen, M.D.'s update on the very latest research.
Debate continues to rage over how much of a role HIV infection and HAART play in the development of heart disease. Mark Holodniy, M.D. reports on a study that found patients on protease inhibitor-containing regimens suffered heart attacks at much higher rates than patients on non-PI-containing regimens.
Coverage From Other Sources
For activism updates from AIDS Action, as well as more conference news from the Centers for Disease Control, the International AIDS Conference itself, and other sources, browse through our archive!
Audio and Video Feeds From Barcelona
Sick of reading reports from the International AIDS Conference? Why not watch or listen to them instead? In partnership with the Kaiser Family Foundation, The Body offers excellent, informative audio and video reports on conference developments. Here are a couple highlights:
Former U.S. President Bill Clinton and former South African President Nelson Mandela close the XIV International AIDS Conference with moving speeches on shattering the stigma against HIV-positive people and pushing forward to crush the epidemic.
In an up-close interview, Peter Piot, the executive director of UNAIDS, reveals what brought him to the front lines of the HIV/AIDS battle -- and why he decided to become involved with the epidemic in the first place.
Browse the rest of our audio/video coverage here!
Nonoxynol-9 Warnings Go Ignored
The microbicide nonoxynol-9 has been shown to actually increase a person's risk of HIV infection -- especially when used rectally -- yet it's still being used by condom and lubrication manufacturers. Read all about this in AIDS Treatment News.
Viagra Use Increases STD Risk?
New data highlights a significant relationship between Viagra use and sexual risk behaviors, drug use and STD infection among a sample of gay and bisexual men in San Francisco.
The Vanishing Wasting Treatment
The last regularly available version of nandrolone, a drug widely used to treat AIDS wasting, was suddenly withdrawn in the U.S. in May, and has largely disappeared from pharmacies. Here are some leads on getting it.
The AIDS Battle: We're in It for the Long Haul
"I don't think we will see, in our lifetime, the end of AIDS and of the AIDS epidemic," said Peter Piot, executive director of UNAIDS. "I think we need to start reasoning in terms of generations." For more on the latest advocacy news, read AIDS Action's weekly update.
Recycling Meds Makes a Difference in Africa
A U.S.-based program to recycle the unused prescription medications of people with AIDS is delivering "a miracle" to a small group of Nigerians with AIDS. The drugs are from patients who have either changed or abandoned their regimens.
HAART: Great Against AIDS, Bad for Your Liver
The benefits of combination therapy that have led to dramatic decreases in opportunistic infections and AIDS deaths over the past several years are accompanied by drawbacks. Some of these side effects are hepatotoxic -- the scary-sounding term for something that can harm the liver. Read ACRIA Update's review of this important subject.
Hepatitis G: The "Good" Coinfection?
Throughout the course of the AIDS epidemic, many coinfections have been investigated as possible causes of faster disease progression. But recent studies have suggested that there may be one that actually benefits people with HIV.
HIV Risk Greater for Young Women
AIDS threatens to reach epidemic proportions among young women, the United Nations says.
Drug Assistance Programs Dying
AIDS Treatment News takes an in-depth look at why the U.S. AIDS Drug Assistance Program is running out of money in many states -- and what might be done to improve the situation.
A Selection of the Top HIV/AIDS Stories From Across the Internet
Can Massive Prevention Efforts Avert 29 Million New Cases of HIV by 2010?
Joan Stephenson, Ph.D. offers her analysis
From Journal of the American Medical Association (July 17, 2002)
Right-Wing Threat Over HIV-Positive Muppet
Several U.S. politicians tell PBS to axe plans to introduce a young muppet with HIV to its South African Sesame Street program
From The Independent (London) (July 16, 2002)
Improved Drug Regimens Help Patients Take Their Medicine
A rundown of recent efforts to simplify people's drug-taking schedules
From The New York Times (free registration required) (July 15, 2002)
Whistling Past the Global Graveyard
Soon, average life expectancy will dip below 40 years in ten African countries
From The New York Times (free registration required) (July 14, 2002)
Experts: AIDS Threatens World Business, Security
From National Public Radio (RealAudio file) (July 12, 2002)
Database of Antiretroviral Drug Interactions
Search through HIV InSite's new, comprehensive, fully referenced database of interactions involving at least one antiretroviral drug